Capstone Therapeutics Corp. Announces Stockholder Approval of "Put Right" and Name Change; Management to Host Conference Call
21 mai 2010 14h07 HE
|
Capstone Therapeutics
TEMPE, Ariz., May 21, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), announced that at the Company's Annual Meeting of Stockholders held...
Capstone Therapeutics to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
14 mai 2010 15h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., May 14, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics(Nasdaq:CAPS) is scheduled to make a presentation at the Rodman & Renshaw 6th Annual Global Healthcare Conference, Grosvenor...
Capstone Therapeutics Announces Continuation of Second of Two AZX100 Phase 2 Clinical Trials in Keloid Scarring
12 mai 2010 08h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., May 12, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today it has completed a limited analysis of a subset of data from the second of its two ongoing...
Capstone Therapeutics Announces Compliance With Nasdaq Listing Rules for Continued Listing on The Nasdaq Capital Market
05 mars 2010 08h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., March 5, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (the "Company") (Nasdaq:CAPS) today announced it received a letter on March 4, 2010 from The Nasdaq Stock Market notifying the...
Capstone Therapeutics Announces Continuation of AZX100 Phase 2 Clinical Trial in Keloid Scarring
02 mars 2010 14h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., March 2, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today it has completed a limited analysis of a subset of data from one of its two ongoing AZX100 Phase 2a...
Capstone Therapeutics 'Puts' Stockholders First; Company to Propose Stockholder Put for Approval at Annual Meeting
17 févr. 2010 08h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., Feb. 17, 2010 (GLOBE NEWSWIRE) -- OrthoLogic Corp., d/b/a Capstone Therapeutics (Nasdaq:CAPS) (the Company) announced today that it intends to propose at its 2010 Annual Meeting of...
Capstone Therapeutics to Host Quarterly Update Conference Call
10 févr. 2010 09h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., Feb. 10, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company") will host a conference call and webcast on Wednesday, February 17,...
Capstone Therapeutics to Present at 3rd Annual European Life Science CEO Forum
09 févr. 2010 08h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the 3rd Annual European Life Science CEO Forum, SIX Swiss Exchange,...
Capstone Therapeutics to Present at Biotech Showcase 2010
11 janv. 2010 14h40 HE
|
Capstone Therapeutics
TEMPE, Ariz., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the Biotech Showcase 2010 at the Marines' Memorial Club & Hotel, 609...
Capstone Therapeutics Announces Completion of Enrollment for AZX100 Phase 2 Clinical Trial in Dermal Scarring Following Shoulder Surgery
05 janv. 2010 12h14 HE
|
Capstone Therapeutics
TEMPE, Ariz., Jan. 5, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the completion of enrollment for its AZX100 Phase 2 clinical trial in dermal scarring following...